{"id":"W7028370904","doi":"","title":"Enanta Pharmaceuticals Reports Financial Results for Its Fiscal Third Quarter Ended June 30, 2014 - NASDAQ (NASDAQ01) News","year":2014,"lang":"en","type":"other","venue":"","topic":"Ancient and Medieval Archaeology Studies","field":"Arts and Humanities","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Term (time); Revenue; Work (physics); Fiscal year","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002083384,0.0008381364,0.0006776045,0.001310161,0.002441314,0.00637824,0.00130434,0.005495552,0.4202712],"category_scores_gemma":[0.003820652,0.0004161689,0.0008273327,0.0007325219,0.0007605195,0.001803594,0.001603186,0.003787465,0.2294697],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002674916,"about_ca_system_score_gemma":0.007890652,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01850506,"about_ca_topic_score_gemma":0.04867837,"domain_scores_codex":[0.9984844,0.0000897154,0.00004821213,0.00009958178,0.0009765275,0.0003015403],"domain_scores_gemma":[0.9969391,0.0002412918,0.0001464947,0.000131328,0.001713179,0.0008287009],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000430458,0.00004430097,0.00006408883,0.00001830925,0.000001811494,0.00003137406,0.000004572116,0.00001647123,0.0000723349,0.0007805846,0.9882891,0.01063396],"study_design_scores_gemma":[0.00003281512,0.00004132406,0.0004916461,0.00003348708,0.000002833586,0.0000386563,0.0000310329,0.00007636938,0.0002568934,0.0004404116,0.9985479,0.000006544436],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.0008874541,0.001839406,0.0003506665,0.02591453,0.01202326,0.0002394346,0.007493069,0.001531846,0.9497203],"genre_scores_gemma":[0.001647286,0.0006529388,0.0001754034,0.003524124,0.0006742155,0.00003388939,0.001537887,0.0001346484,0.9916195],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.4202712,"threshold_uncertainty_score":0.8269128,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04140904497674174,"score_gpt":0.2923484160810949,"score_spread":0.2509393711043531,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}